Center for Scientific Review; Notice of Closed Meetings, 8651-8652 [2021-02491]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 24 / Monday, February 8, 2021 / Notices
(OMB control number: 0938–0618);
Frequency: Quarterly and occasionally;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
50; Total Annual Responses: 40; Total
Annual Hours: 3,200. (For policy
questions regarding this collection
contact Stuart Goldstein at 410–786–
0694.)
Dated: February 3, 2021.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2021–02524 Filed 2–5–21; 8:45 am]
BILLING CODE 4120–01–P
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Gerald L. McLaughlin,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda,
MD 20892 (301) 827–5819 gm145a@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: February 2, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2021–02495 Filed 2–5–21; 8:45 am]
National Institute on Drug Abuse;
Notice of Closed Meetings
BILLING CODE 4140–01–P
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; DeviceBased Treatments for Substance Use
Disorders (UG3/UH3, Clinical Trial
Optional).
Date: February 26, 2021.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ivan K. Navarro, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, 301 North Stonestreet
Avenue, MSC 6021, Bethesda, MD 20892,
(301) 827–5833, ivan.navarro@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Advancing HIV/AIDS Research through
Computational Neuroscience FOA (R01—
Clinical Trial Optional).
Date: March 3, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
20:48 Feb 05, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Integrative and
Clinical Endocrinology and
Reproduction Study Section, February
18, 2021, 09:00 a.m. to February 19,
2021, 07:00 p.m., National Institutes of
Health, Rockledge II, 6701 Rockledge
Drive, Bethesda, MD 20892 which was
published in the Federal Register on
January 22, 2021, 86 FR 6659.
This notice is being amended to
change the meeting date from 2/18/
2021—2/19/2021 to 2/18/2021. The
meeting is closed to the public.
Dated: February 2, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
8651
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders C Translational Neural, Brain, and
Pain Relief Devices.
Date: March 1–2, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Diana M. Cummings,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute of
Neurological Disorders and Stroke, NIH,
NSC, 6001 Executive Blvd., Suite 3208,
Rockville, MD 20852, cummingsdi@
ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: February 2, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–02496 Filed 2–5–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
[FR Doc. 2021–02492 Filed 2–5–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\08FEN1.SGM
08FEN1
8652
Federal Register / Vol. 86, No. 24 / Monday, February 8, 2021 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; IRAP:
Infectious Disease Epidemiology.
Date: March 2–3, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Steele, Ph.D.,
Scientific Review Officer, PSE IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, 301–594–
6594, steeleln@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
CounterACT—Countermeasures against
Chemical Threats.
Date: March 3, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Geoffrey G. Schofield,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040–A,
MSC 7850, Bethesda, MD 20892, 301–435–
1235, geoffreys@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Academic Industrial Partnerships for
Translation of Medical Technologies.
Date: March 4–5, 2021.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, (301) 237–
9870, xuguofen@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Renal/
Urological Small Business Activities.
Date: March 4, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Santanu Banerjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 2106,
Bethesda, MD 20892, (301) 435–5947,
banerjees5@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Novel Genomic Technology Development.
Date: March 4, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
20:48 Feb 05, 2021
Jkt 253001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Methode Bacanamwo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200
Bethesda, MD 20892, 301–827–7088,
methode.bacanamwo@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Therapeutic
Development and Preclinical Studies.
Date: March 4–5, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard D. Schneiderman,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
Bethesda, MD 20817, 301–402–3995,
richard.schneiderman@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Organization and Delivery of Health Services.
Date: March 4, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Bellinger, Ph.D.,
Scientific Review Administrator, Center for
Scientific of Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158
Bethesda, MD 20892, 301–827–4446,
bellingerjd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Neurodevelopment, Synaptic
Plasticity and Neurodegeneration.
Date: March 4–5, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tina Tze-Tsang Tang,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Suite 3030,
Bethesda, MD 20817, (301) 435–4436, tangt@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Topics in Instrumentation and Systems
Development.
Date: March 4, 2021.
Time: 9:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kee Forbes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5148,
MSC 7806, Bethesda, MD 20892, 301–272–
4865, kee.forbes@nih.gov.
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Sensory and Motor
Neuroscience, Cognition and Perception
Date: March 4–5, 2021.
Time: 9:30 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Cibu P. Thomas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, Bethesda, MD 20894 (301) 402–4341,
thomascp@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
CounterACT—Countermeasures Against
Chemical Threats (CounterACT) Research
Centers of Excellence.
Date: March 4–5, 2021.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Geoffrey G. Schofield,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040–A,
MSC 7850, Bethesda, MD 20892, 301–435–
1235, geoffreys@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 2, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–02491 Filed 2–5–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–7038–N–01]
60-Day Notice of Proposed Information
Collection: Application for Roster
Personnel (Appraisers) Designation
and Appraisal Reports
Office of the Assistant
Secretary for Housing—Federal Housing
Commissioner, HUD.
ACTION: Notice.
AGENCY:
The Department of Housing
and Urban Development (HUD) is
seeking approval from the Office of
Management and Budget (OMB) for the
information collection described below.
In accordance with the Paperwork
Reduction Act, HUD is requesting
comment from all interested parties on
the proposed collection of information.
SUMMARY:
E:\FR\FM\08FEN1.SGM
08FEN1
]]>Agencies
[Federal Register Volume 86, Number 24 (Monday, February 8, 2021)]
[Notices]
[Pages 8651-8652]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02491]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which
[[Page 8652]]
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; IRAP: Infectious Disease Epidemiology.
Date: March 2-3, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Steele, Ph.D., Scientific Review Officer,
PSE IRG, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD
20892, 301-594-6594, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: CounterACT--Countermeasures against Chemical
Threats.
Date: March 3, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Geoffrey G. Schofield, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040-A, MSC 7850, Bethesda, MD
20892, 301-435-1235, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Academic Industrial Partnerships for Translation
of Medical Technologies.
Date: March 4-5, 2021.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, (301) 237-
9870, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Renal/Urological Small Business Activities.
Date: March 4, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Santanu Banerjee, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institute of Health,
6701 Rockledge Drive, Room 2106, Bethesda, MD 20892, (301) 435-5947,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Novel Genomic Technology Development.
Date: March 4, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Methode Bacanamwo, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200 Bethesda, MD 20892, 301-827-
7088, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Therapeutic Development and Preclinical Studies.
Date: March 4-5, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard D. Schneiderman, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138, Bethesda, MD 20817, 301-
402-3995, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Organization and Delivery of Health Services.
Date: March 4, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Bellinger, Ph.D., Scientific Review
Administrator, Center for Scientific of Review, National Institutes
of Health, 6701 Rockledge Drive, Room 3158 Bethesda, MD 20892, 301-
827-4446, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Neurodevelopment, Synaptic Plasticity and
Neurodegeneration.
Date: March 4-5, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tina Tze-Tsang Tang, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Suite 3030, Bethesda, MD 20817, (301)
435-4436, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Topics in Instrumentation and Systems Development.
Date: March 4, 2021.
Time: 9:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kee Forbes, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5148, MSC 7806, Bethesda, MD 20892, 301-272-
4865, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Sensory and Motor Neuroscience, Cognition and
Perception
Date: March 4-5, 2021.
Time: 9:30 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Cibu P. Thomas, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, Bethesda, MD 20894 (301) 402-4341, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: CounterACT--Countermeasures Against Chemical
Threats (CounterACT) Research Centers of Excellence.
Date: March 4-5, 2021.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Geoffrey G. Schofield, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040-A, MSC 7850, Bethesda, MD
20892, 301-435-1235, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 2, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-02491 Filed 2-5-21; 8:45 am]
BILLING CODE 4140-01-P
